|
[1]AMODIO P,MONTAGNESE S,GATTA A,et al.Characteristics of minimal hepatic encephalopathy[J].Metab Brain Dis,2004,19(3-4):253-267.
|
|
[2]CORDOBA J.New assessment of hepatic encephalopathy[J].J Hepatol,2011,54(5):1030-1040.
|
|
[3]GHOSH S,van HEEL D,PLAYFORD RJ.Probiotics in inflammatory boweldisease:is it all gut flora modulation[J].Gut,2004,53(5):620-622.
|
|
[4]BAJAJ JS.Minimal hepatic encephalopathy matters in daily life[J].World J Gastroenterol,2008,14(23):3609-3615.
|
|
[5]ROMERO-GOMEZ M,BOZA F,GARCIA-VALDECASAS MS,et al.Subclinical hepatic encephalopathy predicts the development of overthepatic encephalopathy[J].Am J Gastroenterol,2001,96(27):18-23.
|
|
[6]ROMERO-GOMEZ M,GRANDE L,CAMACHO I,et al.Alteredresponse to oral glutamine challenge as prognostic factor for overt episodes inpatients with minimal hepatic encephalopathy[J].J Hepatol,2002,37(6):781-787.
|
|
[7]ISHII T,TAKATORI K,IIDA K,et al.Optimum conditions for the13C-phenylalanine breath test[J].Chem Pharm Bull,1998,46(8):1330-1332.
|
|
[8]DHIMAN RK,SARASWAT VA,SHARMA BK,et al.Minimal hepatic encephalopathy:consensus statement of a working party of the Indian National Association for Study of the Liver[J].J Gastroenterol Hepatol,2010,25(6):1029-1041.
|
|
[9]LUO M,LI L,YANG EN,et al.Relationship between interleukin-6 and ammonia in patients with minimal hepatic encephalopathy due to liver cirrhosis[J].Hepatol Res,2012,42(12):1202-1210.
|
|
[10]OELTZSCHNER G,BUTZ M,BAUMGARTEN TJ,et al.Low visual cortex GABA levels in hepatic encephalopathy:links to bloodammonia,critical flicker frequency,and brain osmolytes[J].Metab Brain,2015,30(6):1429-1438.
|
|
[11]l LANSOLA M,MONTOLIU C,AGUSTI A,et al.Interplay between glutamatergic and GABAergic neurotransmission alterations in cognitive and motor impairment in minimal hepatic encephalopathy[J].Neurochem Int,2015,12(88):15-19.
|
|
[12]QI R,ZHANG L,WU S,et al.Altered resting-statebrain activity at functional MR imaging during the progression of hepatic encephalopathy[J].Radiology,2012,264(1):187-195.
|
|
[13]CHEN HJ,ZHU XQ,JIAO Y,et al.Abnormal baseline brain activity in low-grade hepatic encephalopathy:a resting-state f MRI study[J].J Neurol Sci,2012,318(1-2):140-145.
|
|
[14]LV XF,YE M,HAN LJ,et al.Abnormal baseline brainactivity in patients with HBV-related cirrhosis without overt hepatic encephalopathy revealed by resting-state functional MRI[J].Metab Brain Dis,2013,28(3):485-492.
|
|
[15]MONTOLIU C,PIEDRAFITA B,SERRA MA,et al.IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy[J].J Clin Gastroenterol,2009,43(3):272-279.
|
|
[16]BEMEUR C,QU H,DESJARDINS P,et al.IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure[J].Neurochem Int,2010,56(2):213-215.
|
|
[17]ONAL IK,AKDOGAN M,OZTAS E,et al.Does interleukin-18play a role in the pathogenesis of hepatic encephalopathy[J].Hepatogastroenterology,2011,58(106):497-502.
|
|
[18]LOCKWOOD AH,WEISSENBORN K,BOKEMEYER M,et al.Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholiccirrhotics[J].Metab Brain Dis,2002,17(1):29-40.
|
|
[19]HERNNDEZ-RABAZA V,CABRERA-PASTOR A,TAOROGONZLEZ L,et al.Hyperammonemia induces glial activation,neuroinflammation and alters neurotransmitter receptors in hippocampus,impairing spatial learning:reversal by sulforaphane[J].J Neuroinflammation,2016,13:41.
|
|
[20]MULLENKD.Review of the final report of the 1998 working party ondefinition,nomenclature and diagnosis of hepatic encephalopathy[J].Aliment Pharmacol Ther,2007,25(Suppl 1):11-16.
|
|
[21]FERENCI P,LOCKWOOD A,MULLEN K,et al.Hepatic encephalopathy-definition,nomenclature,diagnosis,and quantification:final report of the working party at the 11th World Congresses of Gastroenterology,Vienna,1998[J].Hepatology,2002,35(3):716-721.
|
|
[22]ROMERO-GOMEZ M,CORDOBA J,JOVER R,et al.Value of the critical flicker frequencyin patients with minimal hepaticencephalopathy[J].Hepatology,2007,45(4):879-885.
|
|
[23]AMODIO P,CAMPAGNA F,OLIANAS S,et al.Detection of minimal hepatic normalization and optimization of the psychometric hepatic encephalopathy score.A neuropsychological and quantified EEG study[J].J Hepatol,2008,49(3):346-356.
|
|
[24]ROBIN H,TAREK H,MEGHAC,et al.Cognitive functioning and psychiatric symptom atology in patients with chronic hepatit is C[J].J Int Neuropsychol Soc,2003,9(1):847-854.
|
|
[25]ZHAO K,ZHANG YX.Treatment of minimal hepatic encephalopathy[J].J Clin Hepatol,2014,30(10):1094-1096.(in Chinese)赵凯,张跃新.轻微肝性脑病的治疗现状[J].临床肝胆病杂志,2014,30(10):1094-1096.
|
|
[26]WANG GD,SU QF,ZHANG HW.Efficacy of naloxone versus lactulose in treatment of minimal hepatic encephalopathy in patients with liver cirrhosis:a comparative analysis[J].China Prac Med,2012,7(34):123-124.(in Chinese)王国栋,苏钦峰,张红伟.纳洛酮乳果糖治疗肝硬化轻微肝性脑病对照分析[J].中国实用医药,2012,7(34):123-124.
|
|
[27]LLAMAS MA,ALLER MA,MARQUINA D,et al.Bacterial translocation to mesenteric lymph nodes increases in chronic portal hypertensive rats[J].Dig Dis Sci,2010,55(8):2244-2254.
|
|
[28]GIBSON GR,WANG X.Regulatory effects of bifidobacteria on the growth of other colonic bacteria[J].Appl Bacteriol,2012,77(4):412-420.
|
|
[29]MARCHESI JR,DUTILH BE,HALL N,et al.Towards the human colorectal cancer microbiome[J].PLo S One,2011,6(5):e20447.
|
|
[30]CHEN SY,LI ZZ,CHEN F.The research of safety and function of probiotics in human gut[J].Chin J Microb,2007,4(19):397-398.
|
|
[31]RIORDAN SM,WILLIAMS R.Gut flora and hepatic encephalopathy in patients with cirrhosis[J].N Engl J Med,2010,362(12):1140-1142.
|
|
[32]SHUKLA S,SHUKLA A,MEHBOOB S,et al.Meta-analysis:the effects of gut flora modulationusing prebiotics,probiotics and synbiotics on minimal hepatic encephalopathy[J].Aliment Pharmacol Ther,2011,33(6):662-671.
|
|
[33]LUO M.Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy:a meta-analysis[J].Eur J Gastroenterol Hepatol,2011,23(12):1250-1257.
|
|
[34]PRASAD S.Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encepahlopathy[J].Hepatology,2007,45(3):549-559.
|
|
[35]LI YQ,CHEN ZF,FENG SG,et al.The therapeutic effects of naloxone on 36 patients with subclinical hepatic encephalopathy[J].Med Inf,2005,18(5):498-500.(in Chinese)李英强,陈志锋,冯少刚,等.纳洛酮治疗亚临床型肝性脑病疗效观察[J].医学信息,2005,18(5):498-500.
|
|
[36]BASS NM,MULLEN KD,SANYAL A,et al.Rifaximin treatment in hepaticencephalopathy[J].N Engl J Med,2010,362(12):1071-1072.
|
|
[37]SIDHU SS,GOYAL O,MISHRA BP,et al.Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy(the RIME Trial)[J].Am J Gastroenterol,2011,106(2):307-316.
|
|
[38]ZHANG YY,FENG YK,CAO B,et al.Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis[J].Int J Clin Exp Med,2015,8(2):2954-2957.
|
|
[39]SHARMA K,PANT S,MISRA S,et al.Effect of Rifaximin,Probiotics,and l-Ornithine l-Aspartate on Minimal Hepatic Encephalopathy:a randomized controlled trial[J].Saudi J Gastroenterol,2014,20(4):225-232.
|
|
[40]ZHANG HB.The development of minimal hepatic encephalopathy[J].J Emerg Tradit Chin Med,1997,6(2):87-90.(in Chinese)张洪斌.肝性脑病的中医研究进展[J].中国中医急症,1997,6(2):87-90.
|
|
[41]YAO C,ZHONG Y,YAO F,et al.A review on treating minimal hepatic encephalopathy in the integrative medicine[J].Hunan J Tradit Chin Med,2015,31(1):149-150.(in Chinese)姚春,钟宇,姚凡,等.中西医治疗轻微型肝性脑病的研究进展[J].湖南中医杂志,2015,31(1):149-150.
|
|
[42]WEI X,CHENG WL,ZHANG RZ.Efficacy of Rheum officinale decoction in treatment of minimal hepatic encephalopathy:a clinical study[J].J Changchun Univ Tradit Chin Med,2011,27(1):26-27.(in Chinese)韦新,程万里,张荣臻.大黄煎剂治疗轻微肝性脑病的临床研究[J].长春中医药大学学报,2011,27(1):26-27.
|
|
[43]LIU H,LIANG Y,LIU YY,et al.Therapeutical effects of rehmannia and stores in on minimal hepatic encephalopathy in rat model[J].Chin J Rehabil Theory Pract,2010,16(10):904-906.(in Chinese)刘赫,梁妍,刘雁勇,等.地黄苏合香合剂对轻微肝性脑病模型大鼠治疗的实验研究[J].中国康复理论与实践,2010,16(10):904-906.
|
|
[44]ZHUO YH,CHEN JJ,WANG LT.Influence of“Qing Kai Granules”on morphology of rat liver with acute liver necrosis[J].Acta Univ Tradit Med Sin Pharmacol Shanghai,2002,16(3):54-56.(in Chinese)卓蕴慧,陈建杰,王灵台.清开颗粒对急性肝坏死大鼠肝脏的组织学影响[J].上海中医药大学学报,2002,16(3):54-56.
|
|
[45]CHANG J,PAN XF,QIU WW.Efficacy of spleen-strengthening and resuscitation-inducing decoction in treatment of subclinical hepatic encephalopathy:a clinical study[J].Med J Chin PLA,2006,31(10):1027.(in Chinese)常洁,潘雪飞,邱蔚蔚.健脾醒神汤治疗亚临床肝性脑病的临床观察[J].解放军医学杂志,2006,31(10):1027.
|
DownLoad: